Wei Hou
Impact in
- Pharmacology top 5%
- Berberine and alkaloids research
Papers in
-
- Circular RNAs in diseases 6
- Genomics and Phylogenetic Studies 5
- Bone Metabolism and Diseases 3
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 6
- Co-authors
- Yanju Bao (15 shared papers)Baojin Hua (15 shared papers)Rui Liu (9 shared papers)Baojin Hua (9 shared papers)Yebo Gao (12 shared papers)Xiangying Kong (9 shared papers)Zhan Shi (6 shared papers)Liping Yang (6 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (6 papers)Chinese Journal of Integrative Medicine (5 papers)Scientific Reports (4 papers)Annals of Palliative Medicine (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Hou
88 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 130
- Pharmacology 141
- Complementary and alternative medicine 123
- Cancer Research 212
- Pharmacology 210
- Molecular Biology 827
Countries citing papers authored by Wei Hou
This map shows the geographic impact of Wei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Hou more than expected).
Fields of papers citing papers by Wei Hou
This network shows the impact of papers produced by Wei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Hou. The network helps show where Wei Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 118 | |
| 2 | 2016 | 110 | |
| 3 | 2014 | 107 | |
| 4 | 2009 | 96 | |
| 5 | 2014 | 83 | |
| 6 | 2014 | 81 | |
| 7 | 2009 | 72 | |
| 8 | 2010 | 66 | |
| 9 | 2014 | 63 | |
| 10 | 2011 | 62 | |
| 11 | 2011 | 57 | |
| 12 | 2015 | 52 | |
| 13 | 2014 | 51 | |
| 14 | 2013 | 43 | |
| 15 | 2017 | 43 | |
| 16 | 2015 | 41 | |
| 17 | 2016 | 36 | |
| 18 | 2013 | 36 | |
| 19 | 2016 | 36 | |
| 20 | 2016 | 33 |
About Wei Hou
Wei Hou is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 91 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Pain Mechanisms and Treatments (7 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers), Genomics and Phylogenetic Studies (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Neuropeptides and Animal Physiology (4 papers) and Bone Metabolism and Diseases (3 papers). The work is most often cited by research in Pharmacology (141 citations), Complementary and alternative medicine (123 citations), Cancer Research (212 citations), Pharmacology (210 citations) and Molecular Biology (827 citations). Wei Hou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yanju Bao, Baojin Hua, Rui Liu, Baojin Hua, Yebo Gao, Xiangying Kong, Zhan Shi, Liping Yang, Qiujun Guo and Honggang Zheng. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Chinese Journal of Integrative Medicine, Scientific Reports, Annals of Palliative Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.